New Delhi: Bharat Biotech, COVAXIN maker, on Thursday, trashed the media reports claiming that the company has submitted the Phase-3 date of the vaccine to the World Health Organisation (WHO). Earlier, news reports claimed that India’s indigenous COVID vaccine ‘Covaxin’ manufacturer Bharat Biotech has submitted its phase-3 clinical trial results to the World Health Organization (WHO) for clearance on Wednesday.Also Read - Expert Panel Green Signals Study on Mixing of Covishield & Covaxin Doses

It also added that the Hyderabad-based Bharat Biotech’s pre-submission meeting has been scheduled on June 23 for evaluation of the WHO’s Emergency Use Listing (EUL) of its indigenous COVID-19 vaccine Covaxin. Also Read - Bharat Biotech Ends Agreement With Brazilian Partners For Covaxin After Graft Allegations

Also Read - AIIMS Delhi to Start Second Dose Trial of COVAXIN on 2-6 Year Olds by Next Week